Stem cell therapy administered at a dose of 2 million cells/kg intravenously biweekly for 44 weeks showed no adverse safety events.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.